Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-08-14

FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)

View source ↗

Summary

FDA approved a supplemental application for the benazepril hydrochloride and hydrochlorothiazide combination (Padagis US LLC), resulting in updated labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benazepril hydrochloride and hydrochlorothiazide (Benazepril hydrochloride and hydrochlorothiazide)

Snippet

SUPPL AP for BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE)